Here's the live share price of Rekvina Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Rekvina Laboratories | 4.44 | -1.35 | 79.90 | 477.82 | 477.82 | 79.45 | 61.02 |
| Sun Pharmaceutical Industries | 1.76 | 10.80 | 10.60 | 6.59 | 8.06 | 25.42 | 22.30 |
| Divi's Laboratories | 0.69 | 9.36 | 9.77 | 3.55 | 8.78 | 27.27 | 10.81 |
| Torrent Pharmaceuticals | 0.13 | 5.53 | 2.95 | 14.91 | 34.31 | 38.04 | 25.98 |
| Cipla | 6.22 | 16.70 | 5.59 | -6.82 | -4.71 | 15.76 | 10.19 |
| Dr. Reddy's Laboratories | 3.38 | 9.74 | 5.33 | 7.43 | 8.27 | 13.95 | 4.95 |
| Lupin | -4.37 | -2.79 | 2.40 | 10.83 | 9.78 | 42.42 | 13.85 |
| Mankind Pharma | 3.29 | 18.11 | 20.41 | 11.68 | -2.08 | 21.87 | 11.98 |
| Zydus Lifesciences | 7.71 | 8.04 | 11.13 | 8.24 | 11.81 | 25.00 | 10.58 |
| Aurobindo Pharma | 1.52 | 9.86 | 27.53 | 22.14 | 24.17 | 35.05 | 8.56 |
| Laurus Labs | 7.73 | 18.58 | 30.77 | 29.56 | 119.24 | 62.04 | 22.88 |
| Biocon | 13.01 | 22.71 | 13.10 | 2.08 | 27.03 | 20.17 | 2.20 |
| Alkem Laboratories | -1.78 | -1.77 | -0.05 | -4.29 | 3.54 | 17.03 | 12.94 |
| Glenmark Pharmaceuticals | -1.85 | 2.68 | 14.24 | 24.39 | 60.47 | 56.22 | 30.89 |
| Abbott India | 4.87 | 7.66 | 6.22 | -5.55 | -7.94 | 9.63 | 11.50 |
| Anthem Biosciences | -0.33 | 7.24 | 13.60 | 17.51 | 7.07 | 2.30 | 1.38 |
| GlaxoSmithKline Pharmaceuticals | -1.74 | 1.46 | -6.04 | -2.00 | -15.19 | 24.01 | 9.97 |
| Ipca Laboratories | 4.20 | 9.88 | 7.80 | 10.53 | 14.87 | 32.51 | 8.22 |
| Ajanta Pharma | 4.21 | 9.41 | 7.40 | 26.23 | 21.67 | 35.49 | 19.32 |
| J B Chemicals & Pharmaceuticals | -1.01 | 7.69 | 7.70 | 16.90 | 29.93 | 27.70 | 25.39 |
Over the last one year, Rekvina Laboratories has gained 477.82% compared to peers like Sun Pharmaceutical Industries (8.06%), Divi's Laboratories (8.78%), Torrent Pharmaceuticals (34.31%). From a 5 year perspective, Rekvina Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (22.30%) and Divi's Laboratories (10.81%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 39.74 | 37.81 |
| 10 | 41.97 | 39.36 |
| 20 | 42.44 | 39.95 |
| 50 | 35.97 | 35.5 |
| 100 | 23.25 | 27.72 |
| 200 | 14.3 | 19.75 |
In the latest quarter, Rekvina Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 58.72% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Apr 10, 2026, 11:13 PM IST IST | Rekvina Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report |
| Apr 10, 2026, 10:41 PM IST IST | Rekvina Laboratories - Shareholder Meeting / Postal Ballot-Outcome of EGM |
| Apr 06, 2026, 11:08 PM IST IST | Rekvina Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Apr 03, 2026, 12:01 AM IST IST | Rekvina Laboratories - Announcement under Regulation 30 (LODR)-Open Offer - Updates |
| Apr 02, 2026, 11:50 PM IST IST | Rekvina Laboratories - Draft Letter of Offer |
Rekvina Laboratories Ltd. is a Public Limited Listed company incorporated on 01/11/1988 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ1988PLC011458 and registration number is 011458. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 3.01 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Rekvina Laboratories is ₹40.91 as on May 15, 2026.
The Rekvina Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Rekvina Laboratories is ₹24.66 Cr as on May 15, 2026.
Today’s highest and lowest price of Rekvina Laboratories are ₹40.91 and ₹40.79.
The 52-week high/low is the highest and lowest price at which Rekvina Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Rekvina Laboratories is ₹46.65 and 52-week low of Rekvina Laboratories is ₹6.75 as on May 15, 2026.
The Rekvina Laboratories has shown returns of 4.98% over the past day, -1.35% for the past month, 79.9% over 3 months, 477.82% over 1 year, 79.45% across 3 years, and 61.02% over 5 years.
P/E ratio of and PB ratio of Rekvina Laboratories are -104.10 and -28.13 on May 15, 2026. While the company gives a dividend yield of 0.00 per annum.